Sriprasert Intira, Pakrashi Tarita, Kimble Thomas, Archer David F
Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Department of Obstetrics and Gynecology, Jones Institute for Reproductive Medicine/Eastern Virginia Medical School, Norfolk, VA USA.
Contracept Reprod Med. 2017 Jul 24;2:20. doi: 10.1186/s40834-017-0047-4. eCollection 2017.
Heavy menstrual bleeding (HMB) is a common gynecological problem that has a significant impact on a woman's quality of life and the activities of daily living. Due to the difficulty in accurately describing menstrual bleeding abnormalities using older terminology, the PALM-COEIN classification system of the Federation Internationale de Gynecologie et d'Obstetrique was proposed to describe and identify the etiology of abnormal endometrial bleeding. As there is no single pathway that is associated with HMB, there are several therapeutic interventions involving different molecular pathways to reduce HMB. This article will highlight the current evidence as it relates to the etiology of HMB as well as medical modalities of treatment.
月经过多是一种常见的妇科问题，对女性的生活质量和日常生活活动有重大影响。由于使用旧术语难以准确描述月经出血异常情况，国际妇产科联盟（Federation Internationale de Gynecologie et d'Obstetrique）提出了PALM-COEIN分类系统来描述和识别异常子宫出血的病因。由于不存在与月经过多相关的单一途径，因此有几种涉及不同分子途径的治疗干预措施来减少月经过多。本文将重点介绍与月经过多病因相关的现有证据以及治疗的医学方式。
